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1. INTRODUCTION 
 Diarrhoea is a condition of having three or more loose or liquid 
stools per day (Kasper et al., 2005). It is a common cause of death in 
Third World Countries and the second most known cause of children 
deaths worldwide (Weber, 1996; WHO, 2009). The loss of fluid and 
electrolytes through diarrhoea can cause dehydration and electrolyte 
imbalances. In 2009, diarrhoea was estimated to have caused 1.1 million 
deaths in people aged 5 years and over, and 1.5 million deaths in children 
under the age of 5 years. Oral rehydration solutions are the treatment of 
choice and have been estimated to have saved 50 million children in the 
past 25 years (Wilson, 2005). Diarrhoea due to infection, may last a few 
days or several weeks, as in persistent diarrhoea. Severe diarrhoea may be 
life threatening due to fluid loss in watery diarrhoea, particularly in 
infants and young children, the malnourished and people with impaired 
immunity. The impact of repeated or persistent diarrhoea on nutrition and 
the effect of malnutrition on susceptibility to infectious diarrhoea, can be 
linked to a vicious cycle amongst children, especially in developing 
countries. It is also associated with other infections such malaria and 
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measles. Chemical irritation of the gastrointestinal tract or non-infectious 
bowel disease can also result in diarrhoea (Kasper et al., 2005).  
 Diarrhoea is caused by a host of bacterial, viral and parasitic 
organisms most of which can be spread by contaminated water. It is more 
common where there is a shortage of clean water for drinking, cooking 
and cleaning, and basic hygiene is important in prevention. Water 
contaminated with human faeces, for example, from municipal sewage, 
septic tanks and latrines is of special concern. Animal faeces also contain 
micro-organisms that can cause diarrhoea. It can also spread from person 
to person, aggravated by poor hygiene. Food is another major cause of 
diarrhoea when it is prepared or stored in unhygienic conditions. Water 
can contaminate food during irrigation, and fish and seafood from 
polluted water may also contribute to the disease. Worldwide, around 1.1 
billion people lack access to improved water and 2.4 billion people have 
no basic sanitation. These will increase susceptibility to diarrhoea 
(Kasper et al., 2005). 
Types and causes of Diarrhoea 
 Secretory diarrhoea means that there is an increase in the active 
secretion, or there is an inhibition of absorption. There is little or no 
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structural damage. The most common cause of this type of diarrhoea is 
cholera which stimulates the secretions of fluids into the gastrointestinal 
tract (GIT) following an increase in salt secretion like sodium chloride. 
The increase in the fluid buildup in the GIT lumen stimulates peristalsis 
resulting in watery diarrhoea (King et al.,2003). 
 Osmotic diarrhoea occurs when too much water is drawn into the 
GIT lumen. This can be the result of malabsorption caused by pancreatic 
disease, in which the nutrients and salts like sodium chloride are left in 
the GIT lumen to pull in water. Osmotic diarrhoea can also be caused by 
osmotic laxatives used in the treatment of constipation. 
 Exudative diarrhoea occurs with the presence of blood or pus in the 
stools. This occurs with inflammatory diseases such as Crohn’s disease or 
ulcerative colitis. Inflammatory diarrhoea occurs when there is damage to 
the mucosal lining, which leads to passive loss of protein rich fluids and a 
decreased ability to absorb these loss fluids. Features of all three types of 
diarrhoea can be found in this type of diarrhoea. This type of diarrhoea 
can be caused by bacterial, viral, parasitic infections or autoimmune 
problems such as inflammatory bowel syndrome. It can also be caused by 
tuberculosis, colon cancer and enteritis. Generally, if there is blood 
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visible in the stools, it is referred to as dysentery which is a symptom of 
bacterial invasion of the colon by a shigella organism (Kasper et al., 
2005; Wilson, 2005). 
Treatment of Diarrhoea 
 Most episodes of diarrhoea are acute and self limiting and may 
reflect food intolerance, bacterial toxin infection or enteric infection. The 
first line management is the prevention or treatment of fluid and 
electrolyte depletion. This is particularly important for infants, children 
and the frail elderly and may be achieved by either homemade or 
commercially available oral rehydration solutions (Kasper et al., 2005). 
Drug treatment 
 Drugs may be used in the management of diarrhoea. The different 
kinds of antidiarrhoeal drugs include anti-propulsives, anti-infectives; 
intestinal absorbents and anti-inflammatory drugs.  
Anti-propulsive 
(1) Loperamide 
 Loperamide is an opioid-receptor agonist and acts on the μ-opioid 
receptors in the myenteric plexus of the large intestine; by itself it does 
not affect the central nervous system like other opioids. It works by 
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decreasing the activity of the myenteric plexus, which, like morphine, 
decreases the tone of the longitudinal smooth muscles but increases tone 
of circular smooth muscles of the intestinal wall. This increases the 
amount of time substances stay in the intestine, allowing for more water 
to be absorbed out of the feacal matter. Loperamide also decreases 
colonic mass movements and suppresses the gastrocolic reflex. It may 
also reduce gastrointestinal secretions. It is given by mouth as an 
antidiarrhoeal drug and as an adjunct in the management of acute or 
chronic diarrhoea and is usually obtainable as 2 mg tablets or 1 mg/5 ml 
syrup. About 40% of the dose of loperamide is reported to be absorbed 
from the gastrointestinal tract to undergo first-pass metabolism in the 
liver and excretion in the faeces via the bile inactive conjugate, there is 
slight urinary excretion. Little intact drug reaches the system circulation. 
The elimination half life is reported to be 1 hour (Altman, 2001; Waller et 
al., 2005). 
 In acute diarrhoea, the usual dose for adults is 2 tablets 
immediately followed by 1 tablet after each loose stool to a maximum of 
8 tablets per day, the usual daily dose is 3 to 4 tablets. In children the 
dose is 5 ml three to four times a day up to 3 days (SAMF, 2010). 
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 In chronic diarrhoea, the usual dose for adults is 2 to 4 tablets daily 
in divided doses subsequently adjusted as necessary. The major side 
effects for loperamide are abdominal pain, bloating, nausea, dry mouth, 
dizziness, and fatigue and hypersensitivity reactions like skin rashes. 
Loperamide has been associated with paralytic ileus particularly in 
infants and young children and death has been reported. Depression of 
CNS, to which children may be more sensitive, may be seen in over 
dosage and naloxone  hydrochloride has been recommended for its 
treatment (Martindale, 2005). 
 Loperamide should not be used when inhibition of peristalsis is to 
be avoided, in particular where ileus or constipation occurs, and should 
be avoided in patients with abdominal distension, acute inflammatory 
bowel disease or antibiotic-associated colitis. It should not be used alone 
in patients with dysentery because dysentery is caused by bacteria and 
therefore, an antibiotic use is necessary. Loperamide should be used with 
caution in patients with hepatic impairment because of its considerable 
first-pass metabolism in the liver and should not be used in infants. 
Concomitant use with co-trimoxazole increases the bioavailability of 
loperamide, apparently by inhibition of the first-pass metabolism 
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(Martindale 2005).It is considered safe for use by breast feeding mothers 
as there has not been any report of clinical effect on the infant associated 
with its use (Kasper et al., 2005). 
(2) Diphenoxylate 
 Diphenoxylate hydrochloride is a synthetic derivative of pethidine 
with little or no analgesic activity. It reduces the intestinal motility and is 
used in the symptomatic treatment of acute or chronic diarrhea. It is well 
absorbed from the gastrointestinal tract and is rapidly and extensively 
metabolized in the liver principally to diphenoxylic acid, which has 
antidiarrhoeal activity. Other metabolites include hydroxydiphenoxylic 
acid. It is excreted mainly as metabolites and their conjugates in the 
faeces and lesser amounts in urine. It may be distributed in breast milk 
(Martindale, 2005). 
 In acute diarrhea, the usual dose for adults is 10mg by mouth 
followed by 5mg every 6 hours, later reduced as the diarrhoea is 
controlled. Suggested initial doses for children 4 to 8 years of age, are 
2.5mg three times a day; 9 to 12 years, 2.5mg four times a day and over 
12 years, 5mg three times a day. Similar initial doses are used for chronic 
diarrhoea and subsequently, reduced as necessary (SAMF, 2010). 
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 Diphenoxylate is related to opioid analgesics and its adverse effects 
and their treatment are similar, particularly in overdosage. The reported 
side effects include anorexia, nausea, vomiting, abdominal distension or 
discomfort, paralytic ileus, toxic megacolon, pancreatitis, headaches, 
drowsiness, restlessness, euphoria, depression, numbness of extremities, 
angioedema, pruritus and swelling of the gums. Signs of overdosage may 
be delayed and patients should be observed for at least 48 hours. Young 
children are particularly susceptible to effects of overdosage.  
 The presence of subclinical dose of atropine in preparation 
containing diphenoxylate may give rise to the side effects of atropine, 
such as blurred vision, constipation, flushing, urinary retention, 
tachycardia, mental confusion and agitation, in susceptible individual or 
in overdosage, thereby, acting as a preventive measure to potential abuse. 
 Diphenoxylate hydrochloride should be avoided in patients with 
jaundice, intestinal obstruction; antibiotic associated colitis or diarrhoea 
associated with enterotoxin-producing bacteria and should be used with 
caution in patients with hepatic impairment. It should also be used with 
caution in young children because of a greater variability of response in 
this age group and is not generally recommended in infants. Patients with 
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inflammatory bowel disease receiving diphenoxylate should be carefully 
observed for signs of toxic megacolon and it should be discontinued 
immediately should abdominal distention occur. There is a theoretical 
risk of hypertensive crisis if it is used with monoamine oxidase inhibitors 
(MAOI’s) due to its structural relationship with pethidine (Kasper et al., 
2005; Wilson, 2005; Martindale, 2005). 
TRADITIONAL HERBAL MEDICINE 
By definition, ‘traditional’ use of herbal medicines implies 
substantial historical use, and this is certainly true for many products that 
are available as ‘traditional herbal medicines’. In many developing 
countries, a large proportion of the population relies on traditional 
practitioners and their armamentarium of medicinal plants in order to 
meet health care needs. Although modern medicine may exist side-by-
side with such traditional practice, herbal medicines have often 
maintained their popularity for historical and cultural reasons. Such 
products have become more widely available commercially, especially in 
developed countries. In this modern setting, ingredients are sometimes 
marketed for uses that were never contemplated in the traditional healing 
systems from which  they  emerged. An  example  is  the  use  of  ephedra  
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(= Ma huang) for weight loss or athletic performance enhancement 
(Shaw, 1998).  
THE ROLE OF HERBAL MEDICINES IN TRADITIONAL 
HEALING  
The pharmacological treatment of disease began long ago with the 
use of herbs (Schulz et al., 2001). Methods of folk healing throughout the 
world commonly used herbs as part of their tradition. 
Traditional Chinese medicine has been used by Chinese people 
from ancient times. Although animal and mineral materials have been 
used, the primary source of remedies is botanical. Of the more than 12 
000 items used by traditional healers, about 500 are in common use. 
Botanical products are used only after some kind of processing, which 
may include, for example, stir-frying or soaking in vinegar or wine. In 
clinical practice, traditional diagnosis may be followed by the 
prescription of a complex and often individualized remedy. Traditional 
Chinese medicine is still in common use in China. More than half the 
population regularly uses traditional remedies, with the highest 
prevalence of use in rural areas. About 5000 traditional remedies are 
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available in China; they account for approximately one fifth of the entire 
Chinese pharmaceutical market (Li, 2000). 
Many herbal remedies found their way from China into the 
Japanese systems of traditional healing. Herbs native to Japan were 
classified in the first pharmacopoeia of Japanese traditional medicine in 
the ninth century (Saito, 2000).  
Ayurveda is a medical system primarily practised in India that has 
been known for nearly 5000 years. It includes diet and herbal remedies, 
while emphasizing the body, mind and spirit in disease prevention and 
treatment (Morgan, 2002). 
MEDICINAL APPLICATIONS, BENEFICIAL EFFECTS AND 
ACTIVE COMPONENTS 
In some cases, the active principles of plant-derived products have 
been isolated and characterized, and their mechanisms of action are 
understood (e.g., ephedrine alkaloids in some species of Ephedra ). For 
many, however, including virtually all of the most common products in 
the marketplace, such information is incomplete or unavailable. This is in 
large part due to the complexity of herbal and botanical preparations; they 
are not pure compounds. It is also a function of the traditionally-held 
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belief that the synergistic combination of several active principles in 
some herbal preparations is responsible for their beneficial effects.  
 
WHO GUIDELINES FOR HERBAL MEDICINES 
In 1992, the WHO Regional Office for the Western Pacific invited 
a group of experts to develop criteria and general principles to guide 
research work on evaluating herbal medicines (WHO, 1993). This group 
recognized the importance of herbal medicines to the health of many 
people throughout the world, stating: ‘A few herbal medicines have 
withstood scientific testing, but others are used simply for traditional 
reasons to protect, restore, or improve health. Most herbal medicines still 
need to be studied scientifically, although the experience obtained from 
their traditional use over the years should not be ignored. As there is not 
enough evidence produced by common scientific approaches to answer 
questions of safety and efficacy about most of the herbal medicines now 
in use, the rational use and further development of herbal medicines will 
be supported by further appropriate scientific studies of these products, 
and thus the development of criteria for such studies’.  
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Table No: 1. Table shows various plants used for the treatment 
of diarrhea 
 
 
S.No PLANT NAME PARTS USED REFERENCE 
1 Alchornea  cordifolia Leaf Agbor et al., 2004 
2 Aristolochia ringens Root Adeyemi et al., 2012 
3 Baphia nitida Leaves Adeyemi and 
Akindele, 2008 
4 Calotropis gigantean Aerial part Chitme,  2004 
5 Capparis  zeylanica Leaf Karanayil et al., 2011 
6 Carum copticum Seed Balaji et al., 2012 
7 Catharanthus roseus Leaf Hassan et al., 2011 
8 Cayratia Pedata Leaves Karthik et al., 2011 
9 Cinnamomum 
zeylanicum 
Bark Rao and lakshmi , 
2012 
10 Combretum sericeum Root Sini et al., 2008 
11 Coriandrum sativum Whole plant Karmakar et al., 2011 
12 Dalbergia 
lanceolaria 
Bark Mujumdar et al., 2005 
13 Delonix regia Flower Shiramane et al., 2011 
14 Ficus religiosa Stem bark Panchawat and 
sisodia,  2012 
15 Geranium incanum 
Burm. f. 
Leaves Amabeoku, 2009 
16 Hippocrataea Africa Root Okokon et al., 2011 
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17 Hyptis siaveolens Leaves Shaikat et al., 2012 
18 Indigofera pulchra Aerial part Mohammed et al., 
2009 
19 Ipomes obscura Leaf Seshadri et al., 2007 
20 Ixora coccinea Flower Maniyar et al., 2010 
21 Murraya koenigii Leaves Sharma et al., 2012 
22 Pterocarpus 
erinaceus 
Leaf Ezeja  et al., 2012 
23 Securinega virosa Leaves, root 
bark, stem  
Magaji  et al., 2007 
24 Strychnos potatorum Dried seeds Biswas et al., 2002 
25 Xanthium indicum Leaves Akter  et al., 2009 
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2. PLANT PROFILE 
 
 
                                 Figure: 1   Kedrostis Foetidissima 
 
BOTANICAL DESCRIPTION 
 
 Botanical Name  : Kedrostis foetidissima(Jacq.) Cogn 
 Class      :  Dicotyledons 
 Subclass     :  Polypetalae 
 Series     :  Calyciflorae 
 Order      :  Passiflorales 
 Family      :  Cucurbitaceae 
 Genus      :  Kedrostis 
 Species      :  Foetidissima 
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VERNACULAR  NAME 
 
 Tamil   : Appakovai 
 Telungu  :  Kukumadumda / Nagadonda 
 Kannada  :  Kukumadumdarnara  
 Bombay   :  Nurakvels 
 
Ecology And Distribution:  
 World wide in distribution. It is Rich in the regions of south Africa 
and Asia. 
In India:  
 The Kedrostis foetidissima is Distributed in the warm and dry areas 
of Gujarat, Punjab, Uttarpradesh, Maharastra & Andhrapradesh and it is 
also found in the Malabar, Deccan and Carnatic regions of India. 
Conservation: 
Kedrostis foetidissima is a least concerned plant and is a threatened 
species it requires severe attention for conservation. 
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Cucurbitaceae: 
The cucurbitaceae is essentially a tropical family containing 110 
genera and 640 species. In India the family is represented by 37 genera 
and about 97 species several of which are cultivated throughout India. 
Plant kedrostis foetidissima (jacq.) Cogn: 
Scandent , Monoceious, Stem slender, Branched, angled, Sparsely 
hairy, Tendrils simple, Filiform, Glabrous. 
Root :  
In Kedrostis  root is perennial due to presence of  Root Stocks. 
Stem:  
It is slender distance between node and inter node 8.5 10.2 cm 
long. 
Leaves:  
Leaves are 5.8 cm long, 7.1 cm breadth and as broad as long 
membranous, arbicular in out line, bright green, hairy and more or less 
scab rid on both sides margins entire or distantly toothed, cordate at the 
base. Some time five angled are sublobate, the lobes sub acute, apiculate, 
Petioles: 
Petioles are 2.7-2.8 cm long, hairy. 
                                                                                        PLANT PROFILE 
 
DEPARTMENT OF PHARMACOLOGY Page 18 
 
Male Flower:  
In male flower peduncles filiform 2.9 cm long, 0.7 mm at the apex, 
pedicles capillary 0.7 mm long usually bracteolate at the base, male 
flower length 0.7 mm across, in racemes. Calyx tube compunlate calyx 
length 0.3 mm, rounded at the base teeth minute. Corolla pale yellow. 
Segment oblong lanceolate, acute, 0.6 mm long pubescent, stamens 3 
inserted in the middle of calyx tube filaments free anthers sub orbicular. 
Female Flower:  
In female flower Peduncles 1.3 cm long, beaked, pubescent, ovary 
oblong 0.9 mm long, petles are 0.6 mm long, calyx 0.2 mm style 
glabrous, stylar disc small stigma 3 fid. Flowers are flask shaped. 2 mm 
style glabrous, stylar disc small stigma 3 fid. Flower are flask shaped. 
Fruit:  
Fruit sub sessile, Deep red, about4.9 cm long and beaks are 0.6 mm 
breadth, hair of fruit 0.2 0.1 mm ovaid, tapering into a long narrow beak, 
pubescent. 
Seed:  
Seeds   4 mm   long,   ovaid,  with   a   narrow   sharp  wing  brown 
( Nirmala J and Pandian, 2013). 
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Traditional Uses: 
The leaf juice of Kedrostis foetidissima, locally named as 
Appakovai, applied externally on joints cures diarrhoea in babies of 3-4 
months. Medicinal use, preparation and administration modes of 299 
plant species belonging to168 genera in 68 families medicinal plants of 
Bulamogi in Uganda shows a record , that Kedrostis foetidissima, wild 
herb, was used in treatment of diarrhoea and measles. Leaf infusion was 
taken in treating diarrhoea and leaf decoction was taken orally in the 
treatment of measles (Ragupathy, 2008  and  Tabuti et al., 2003). 
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3. LITERATURE REVIEW 
 Otenio et al., 2008, reported the use of Kedrostis foetidissima, 
which was one of the plant in multi plant extract used in the 
treatment of opportunistic infection. 
 Otenio et al., 2007, documented the medicinal herb Kedrostis 
foetidissima along with P.vogelii, recommended for further 
pharmacological test on HIV cases and for domestication to serve 
them from local extinction. 
 Kamatenesi et al., 2011, suggested the roots of Kedrostis 
foetidissima (jacq.)cogn. crushed, mixed in cold water is taken 
once a day for the treatment of Measles. 
 Giday, 2001, renowned the use of whole plant of Kedrostis 
foetidissima, for curing chest pain and its leaves used as a 
traditional veterinary medicine in the treatment of ALOYE . 
 An ethnodiagnostic study conducted by Ole-Miaron, 2003, reports 
Kedrostis foetidissima (jacq.)cogn., as a rare plant with a very 
unpleasant smell but cattle feed on intravenously. The leaves are 
crushed and fed to cattle suffering from pasture bloat and frothy 
bloat. 
                                                                             LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOLOGY Page 21 
 
 Priyavardhini et al., 2008, reported the antibacterial activity of 
chloroform extract of leaf and stem of Kedrostis foetidissima 
against bacteria like Streptococcus aureus, Escherichia coli, 
Pseudomonus aeruginosa, Klebsiella pneumonia, Serratia 
marcescens. 
 Otenio et al., 1998, reported the aqueous extract of Kedrostis 
foetidissima  was active against the measles virus Leishmania 
denovani, the visceral Leishmania Parasite, as well as 
Trypanosoma brucei. 
 Choene and Motadi, 2012, explained the Anti-proliferative effects 
of the methanolic extract of kedrostis foetidissima in breast cancer 
cell lines. 
 Amutha and Lalitha, 2013, studied the wound healing activity of 
Leaf and Stem Extract of Kedrostis Foetidissima. 
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4. AIM AND OBJECTIVE OF THE STUDY 
 
Aim of the Study 
 Aim of the study is to screen the anti-diarrhoeal activity of 
ethanolic leaf extract of kedrostis foetidissima  in mice. 
Objective of the Study 
Diarrhoea is common disease annually about 4 to 5 million 
diarrhoeal deaths occur  in the developing countries through out the  
world (Senthil Nagaraj D et al., 2013). Now drug available in market for 
diarrhoea has variety of side effect. So there is need for a continuing 
search for effective anti-diarrhoeal drugs without side effect. 
In recent years, the interest in plant-based medicine has increased 
worldwide. kedrostis foetidissima  have many therapeutic uses in the 
practice of traditional medicine. This herb has been used to treat a 
number of disorders including inflammation, malaria, fever, worms, pain, 
diuresis, cancer, abortion, and various gastro-intestinal disorders. There is 
no scientific evidence on the antidiarrheal activity of kedrostis 
foetidissima. Hence, the present study was designed to evaluate the 
claims of the native practitioners. 
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5. PLAN OF THE WORK 
1. Collection of Plant Material. 
2. Authentication of Plant. 
3. Extraction of plant material by maceration method using ethanol. 
4. Preliminary phyto-chemical analysis. 
5. Ethical consideration. 
6. Pharmacological evaluation  
 -  Measurement of faecal output  
 -  Castor oil model 
 -  Gastrointestinal transit test. 
7.   Statistical Analysis. 
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6. MATERIALS AND METHODS 
Plant Material 
Collection and Authentication 
 The leaves of Kedrostis foetidissima was collected from Kolli hills. 
It was identified and authenticated as Kedrostis foetidissima by Scientist 
‘F’ Botanical survey of India, Southern Regional Centre, Tamilnadu 
Agriculture University, Coimbatore. The voucher specimen 
(BSI/SRC/5/23/2015/Tech/1789) has been deposited in department for 
further references. 
Preparation of Extract 
 The collected leaves were, shade dried and then ground into coarse 
powder. The powder was then subjected to exhaustive extraction by a 
maceration process using 90% ethanol as a solvent at room temperature 
for 7 days. The ethanolic extract was concentrated by vacuum distillation 
to dry. The collected extract was stored in desiccators and used for further 
pharmacological study. 
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Phytochemical Analysis (CK Kokate1994, Harsone 2007) 
 A systematic and complete study of crude drugs includes a 
complete investigation of both primary and secondary metabolites 
derived from plant metabolism. Different qualitative test were performed 
for establishing profiles of various extracts for their nature of chemical 
composition. The extracts obtained were subjected to following chemical 
tests for identification of various phytoconstituents as per the methods 
given by Harborne. There were no previously isolated compounds.  
1. TEST FOR STEROLS  
a. Salkowski test: Few drops of concentrated sulphuric acid was added to 
the  chloroform solution, shaken and allowed to stand, appearance 
of red color in lower layer  indicates the presence of sterols.  
b. Liebermann-Burchard test: To the chloroform solution, few drops of 
acetic anhydride was added and mixed well. 1 mL of concentrated 
sulphuric acid was added from the sides of the test tube, 
appearance of reddish brown ring indicates the presence of sterols. 
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2. TEST FOR TRI-TERPENES  
a. Salkowski test: Few drops of concentrated sulphuric acid was added to 
the  chloroform solution, shaken and allowed to stand, appearance 
of golden yellow color  indicates the presence of triterpenes.  
b. Liebermann-Burchard test: To the chloroform solution, few drops of 
acetic anhydride was added and mixed well. 1 mL of concentrated 
sulphuric acid was added from the sides of the test tube, 
appearance of deep red color indicates the presence of triterpenes.  
3. TEST FOR SAPONINS  
a. Foam test: Small amount of extract/ fraction was shaken with little 
quantity of  water, if foam produced persists for 10 minutes; it 
indicates the presence of saponins.  
b. Haemolysis test: To 2 mL of 1.8% sodium chloride solution in two 
test tubes, 2 mL  distilled water was added to one of the test tube 
and to other 2 mL of 1% sample  extract/ fraction was added. 5 
drops of blood was added to each test tube and gently  mixed the 
contents. Haemolysis was observed under the microscope on glass 
slide,  indicates the presence of saponins in the extract.  
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c. Froth test: To 5 ml of extract of the drug added a drop of sodium 
bicarbonate solution.  Shaken the mixture vigorously and left for 3 
minutes. Honey comb like froth is formed.  
4. TEST FOR ALKALOIDS: The various extract/ fractions were 
basified with ammonia and extracted with chloroform. The 
chloroform solution was acidified with dilute hydrochloric acid. 
The acid layer was used for testing the alkaloids.  
a. Wagner’s test (Iodine in Potassium iodide): The acid layer was 
treated with few drops of Wagner’s reagent. Formation of reddish 
brown precipitate indicates the presence of alkaloids. 
b. Mayer’s test (Potassium Mercuric Iodine solution): The acid layer 
was treated with few drops of Mayer’s reagent. Formation of 
creamy white precipitate indicates the presence of alkaloids.  
c. Dragendorff’s reagent (Potassium Bismuth Iodide): The acid layer 
was treated with few drops of Dragendorff’s reagent. Formation of 
reddish brown precipitate indicates the presence of alkaloids.  
d. Hager’s test: The acid layer was treated with few drops of Hager’s 
reagent.  Formation of yellow precipitate indicates the presence of 
alkaloids.  
                                                                    MATERIALS AND METHOD 
 
DEPARTMENT OF PHARMACOLOGY Page 28 
 
5. TEST FOR CARBOHYDRATES: Small amount of extracts/ 
fractions were dissolved in little quantity of distilled water and 
filtered separately. The filtrates were used to test presence of 
carbohydrates.  
a. Molisch’s test: The extract was treated with Molisch reagent and 
concentrated sulphuric acid was added from the sides of the test 
tube to form a layer. A reddish violet ring shows the presence of 
carbohydrates.  
b. Fehling’s test: Filtrates were hydrolyzed with dilute hydrochloric acid, 
neutralized with alkali and heated with equal amount of Fehling’s 
A and B solutions. Formation of green to yellow to red precipitate 
indicated the presence of reducing sugars.  
c. Barfoed’s test: To the filtrate few drops of Barfoed’s reagent was 
added and boiled in water  bath. Brick red precipitate formation 
shows the presence of carbohydrates. 
d. Benedict’s test: to the filtrate added 2 mL Benedict’s reagent and 
boiled in water bath. Green reddish brown precipitate is formed. 
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6. TEST FOR TANNINS  
a. Ferric chloride test: To extracts a few drops of 1% neutral ferric 
chloride solution was added, formation of blackish blue color 
indicates the presence of tannins.  
b. Gelatin test: To the extracts added 1% solution of gelatin containing 
10% sodium chloride. Formation of white precipitate indicates the 
presence of tannins.  
7. TEST FOR FLAVONOIDS  
a. Shinoda test: To the alcoholic solution of extract a few fragments of 
magnesium ribbon and concentrated hydrochloric acid was added. 
Appearance of red to pink color after few minutes indicates the 
presence of Flavonoids.  
b. Ferric chloride test: Few drops of neutral ferric chloride solution were 
added to little quantity of alcoholic extract. Formation of blackish 
green color indicates the presence of phenolic nucleus.  
c. Lead acetate test: To the extract, a few drops of aqueous basic lead 
acetate solution were added. Formation of yellow precipitate 
indicates presence of flavonoids.  
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d. Zinc-hydrochloric acid reduction test: The alcoholic solution was 
treated with a  pinch of zinc dust and few drops of concentrated 
hydrochloric acid. Formation of  magenta color after few minutes 
indicates the presence of flavonoids.  
e. Alkaline reagent test/ NaOH test: To alcoholic solution added few 
drops of sodium hydroxide solution. Intense yellow color which 
disappeared after adding dilute HCl  indicates the presence of 
flavonoids.  
8. TEST FOR LACTONES  
a. Legal test: The extract was dissolved in pyridine and a mixture of 
sodium nitroprusside and sodium hydroxide was added. Deep red 
color indicates the presence of lactones.  
b. Baljet test: To the extract, sodium picrate solution was added. 
Formation of yellow  color indicates the presence of lactones.  
9. TEST FOR AMINO ACID/ PROTEIN  
a. Ninhydrin test: Heated the 3 mL of extract and 3 drops of ninhydrin 
solution in boiling water bath for 10 minutes. Appearance of purple 
color shows the presence of amino acids.  
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b. Biuret test: To 3 mL of extract added 4% NaOH and few drops of 1% 
cooper  sulphate solution. Formation of violet color confirms the 
presence of protein.  
c. Millon’s reagent test: Mixed the extract with millon’s reagent. 
Formation of brick  red precipitate indicates the presence of 
protein.  
d. Xanthoproteic test: To 1 mL of concentrated nitric acid was added 
boiled for 1 minute and liquid ammonia was added. Precipitate is 
formed.   
10. TEST FOR RESINS: Dissolved the extract in acetone and pour the 
solution in to distilled  water. Turbidity indicates the presence of 
resins. 
11. TEST FOR STARCH: dissolved 0.015 gm of iodine and 0.075 gm 
of potassium iodide in 5 mL of distilled water and add 2-3 mL of 
an aqueous extract of drug, blue color is produced. 
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Animals 
Wistar albino mice (20 – 25 gm)  were  used for the study. The 
animals were obtained from animal house, Nandha College of Pharmacy, 
Erode. The animals were placed at random and allocated to treatment 
groups in polypropylene cages with paddy husk as bedding. Animals 
were housed at a temperature of 24±2oC and relative humidity of 30 – 70 
%. A 12:12 light:day cycle was followed. All animals were allowed to 
free access to water and fed with standard commercial pelleted rat chaw 
(M/s. Hindustan Lever Ltd, Mumbai). All the experimental procedures 
and protocols used in this study were reviewed and approved by the 
Institutional Animal Ethics Committee of Nandha College of Pharmacy 
(Reg No: 688 / PO/Re/S/02 / CPCSEA)  and were in accordance with the 
guidelines of the CPCSEA. 
Anti-diarrheal Activity 
Measurement of faecal output 
 Faecal output was measured following the methods of Pillai 
(1992). Four groups of mice (n = 6) were housed singly in separate cages. 
Group I served as the control and received 0.1% CMC (Carboxy Methyl 
Cellulose solution). Groups II & III mice were treated respectively with  
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200 & 400 mg/kg of extract, while group IV mice received Loperamide at 
5 mg/kg, p.o., the standard anti-diarrhoeal drug. Following treatment, the 
faecal materials were collected for 8 h post treatment, were dried in an 
incubator and their weights measured. The percentage faecal output 
(%FOP) was calculated as follows: 
    ft  x 100 
                    % FOP = -------------- 
         fc    
 
where, ft , is the mean faecal weight of each treatment group, and fc is that 
of control group (Akah et al., 1999).  
 
Castor oil model Otshudi et al. (2001) 
 Overnight-fasted mice were randomly divided into four groups (n = 
6). Group I served as the control and received 0.1% CMC (Carboxy 
Methyl Cellulose solution; Groups II & III mice were treated respectively 
with  200 & 400 mg/kg of Kedrostis foetidissima extract, while group IV 
mice received Loperamide at 5 mg/kg, p.o., the standard anti-diarrhoeal 
drug. 1 h later, diarrhoea was induced in all groups by inoculating castor 
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oil (0.5 ml/mouse, p.o.). The numbers of diarrhoeal episodes were 
recorded for each time and cumulative values were calculated for 4 h post 
induction of diarrhoea, and the numbers of animals devoid of diarrhoeal 
droppings at 4 h were considered as a percentage protection from 
diarrhoea. 
 
Gastrointestinal transit test  
 The animals were starved for 16 h prior to the experiment. Group I 
served as the control and received 0.1% CMC (Carboxy Methyl Cellulose 
solution; Groups II & III mice were treated respectively with  200 & 400 
mg/kg of Kedrostis foetidissima extract, while group IV mice received 
Loperamide at 5 mg/kg, p.o., the standard anti-diarrhoeal drug. 5 min 
later, 0.5 ml of charcoal meal was orally inoculated to each mouse. All 
the mice were sacrificed 30 min later, their small intestines from pylorus 
to caecum cut out and distance travelled by the charcoal marker 
measured, and expressed as a percentage of the total length of small 
intestines. The percentage inhibition of the marker transit in the intestine 
was calculated as described by Akah & Offiah (1992). 
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Statistical Analysis 
 Results were expressed as mean ± SEM. The data were analyzed 
by using one way analysis of variance (ANOVA) followed by Dunnet’s t 
test. P values < 0.05 were considered as significant. 
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7. RESULTS 
 
Table No:2.  Qulitative Phytochemical Analysis of Ethanolic  
extract of Kedrostis foetidissima leaves 
 
 
S.No 
 
Plant constituents 
 
Kedrostis  foetidissima 
leaf Extract 
1 Test for sterols + 
2 Test for tri terpenoids + 
3 Test for saponins + 
4 Test for alkaloids 
                 - 
5 Test for carbohydrates 
                 + 
6 Test for tannins 
                 + 
7 Test for flavonoids 
                 + 
8 Test for lactones 
                 - 
9 Test for amino acid and  
proteins 
                    - 
10 Test for resins + 
11 Test for starch 
                 - 
      
 
  +Present 
  - Absent 
 
The result of phytochemical analysis as shown on table. the 
phytochemical analysis reveals the presence of sterols, tri terpenoids, 
saponin, carbohydrates, tannins, flavonoids, resins of ethanolic leaf 
extract of Kedrostis foetidissima.  
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Anti-diarrheal Activity 
Measurement of faecal output 
Table No:3. The table shows the anti-diarrhoeal effect of ethanolic 
leaf extract of Kedrostis foetidissima on the  measurement of faecal 
output in mice 
 
S.No Drug Treatment 
Faecal Weight 
(g)/100 gm 
Mouse 
% Reduction 
1 Control (0.1% CMC) 0.47 ± 0.02 - 
2 Kedrostis foetidissima (200mg/kg) 0.29±0.01*** 51.06 
3 Kedrostis foetidissima (400mg/kg) 0.39±0.02* 38.29 
4 Reference Control Loperamide (5mg/kg) 0.23 ±0.01** 17.01 
  
 
   Values are in mean ± SEM (n=6),  
   *P<0.05 , **P<0.01,  ***P<0.001 Vs Control 
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The anti-diarrhoeal activity of ethanolic leaf extract of Kedrostis foetidissima was 
studied using mice by faecal output method and the result was shown on table 3.     
Treatments of Kedrostis foetidissima leaf extract at 200 & 400 mg/kg, p.o. doses 
could reduce faecal production of the treated mice significantly in a dose-dependant 
manner.  The faecal weight of control group was 0.47 ± 0.02 g/100gm animal. The 
faecal weight of Kedrostis foetidissima leaf extract 200 and 400 mg/kg was 0.29 
±0.01 and 0.39±0.02 g/100gm animal respectively. The faecal output of the reference 
control loperamide was 0.23 ±0.01 g/100gm animal. The % reduction in faecal output 
was recorded to be 51.06 and 38.29  for the extract (200 & 400 mg/kg, respectively) 
and Loperamide it was 17.01 %.   
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Table No: 4. The table shows the anti-diarrhoeal effect of ethanolic 
leaf extract of Kedrostis foetidissima on castor oil induced diarrhoea 
mice. 
 
S.No Drug Treatment No of Diarrhoeal Episodes at 4 hrs % Reduction 
1 Control (0.1% CMC) 8.32±0.03 - 
2 Kedrostis foetidissima (200mg/kg) 4.73±0.02** 43.15 
3 Kedrostis foetidissima (400mg/kg) 3.56±0.01** 57.21 
4 Reference Control Loperamide (5mg/kg) 1.95±0.01*** 76.56 
  
 
   Values are in mean ± SEM (n=6),  
   *P<0.05 , **P<0.01,  ***P<0.001 Vs Control 
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The anti-diarrhoeal activity of ethanolic leaf extract of Kedrostis foetidissima was 
studied using mice by castor oil induced diarrhoea and the result was shown on table 
4.  Treatments of Kedrostis foetidissima leaf extract at 200 & 400 mg/kg, p.o. doses 
could reduce number of diarrhoeal episodes of the treated mice significantly in a 
dose-dependant manner.  The number of diarrhoeal episode of control group was 8.32 
± 0.03. The number of diarrhoeal episode of Kedrostis foetidissima leaf extract 200 
and 400 mg/kg was 4.73 ± 0.02 and 3.56 ± 0.01 respectively. The number of 
diarrhoeal episode of the reference control loperamide was 1.95 ± 0.01. The % 
reduction in faecal output was recorded to be 43.15 % and 57.21 % for the extract 
(200 & 400 mg/kg, respectively) and Loperamide it was 76.56 %.   
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Table No: 5. The table shows the anti-diarrhoeal effect of ethanolic 
leaf extract of Kedrostis foetidissima on intestinal transit using 
charcoal meal in mice. 
S.No Drug Treatment 
Distance travelled 
by Charcoal 
Marker (%) 
1 Control (0.1 % CMC) 73.32 
2 Kedrostis foetidissima (200mg/kg) 52.51** 
3 Kedrostis foetidissima (400mg/kg) 37.63*** 
4 Reference Control Loperamide (5mg/kg) 22.56*** 
  
             Values are in mean ± SEM (n=6),  
 *P<0.05 , **P<0.01,  ***P<0.001 Vs Control 
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The anti-diarrhoeal activity of ethanolic leaf extract of Kedrostis foetidissima 
was studied by intestinal transit method using charcoal meal in mice and the result 
was shown on table 5.  Treatments of Kedrostis foetidissima leaf extract at 200 & 400 
mg/kg, p.o. doses significantly reduced the % of distance travelled by the charcoal 
marker in dose-dependant manner.  The distance travelled by the charcoal marker in 
control group was 73.32 %. The same for Kedrostis foetidissima leaf extract 200 and 
400 mg/kg was 52.5 % and 37.63 % respectively. The reference control loperamide 
showed 22.56 %.   
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8. SUMMARY 
 Diarrhoea accounts for more than 5-8 million deaths worldwide 
each year in age less than 5 years especially in developing countries. To 
combat this problem the world health organization has initiated a 
diarrhoea disease control program to study traditional medicine practices 
and other related aspects together with the evaluation of health education 
and prevention approaches. Plants have been a valuable source of natural 
product for maintaining human health for many years. About 80% of 
individuals from developed countries receive traditional medicines 
including compounds derived from medicinal plants. Such medicinal 
plants can e exploited since it has been shown that they are important 
sources of new chemical substances with potential therapeutic effects. 
Kedrostis foetidissima belonging to the family, Curcubitaceae, 
traditionally used for the treatment of diarrhoea in children. So far no 
scientific evidence available for its antidiarrhoeal  potential, so effort has 
been taken to prove its traditional claim by screening the antidiarrhoeal 
activity of ethanolic leaf extract of Kedrostis foetidissima in mice. 
Phytochemical analysis was carried for the ethanolic leaf extract which 
shows the presence of  tannins, terpenoids, flavanoids.  Adult Wistar 
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albino mice were used in the study for evaluating the antidiarrhoeal 
acitivity. Well established antidiarrhoeal models like Measurement of 
faecal output, Castor oil induced diarrhoea and charcoal meal induced 
gastrointestinal transit test were performed. For above test, the animals 
were divided into 4 groups of six animals each. Group I served as control 
received CMC solution, Group II and III were administered with 200 and 
400 mg/kg of ethanolic leaf extract of Kedrostis foetidissima respectively. 
Group IV served as reference control, received 5mg/kg of Loperamide.  
The result showed that, in measurement of faecal output there was 
significant decrease in feacal out was observed with Kedrostis 
foetidissima, in castor oil induced diarrhoea test, both the doses of 
Kedrostis foetidissima reduced the number of diarrhoeal episodes and in 
charcoal meat test, there was significant decrease in % of distance 
travelled by the charcoal marker in dose-dependent manner. From the 
above it was concluded that, ethanolic leaf extract of Kedrostis 
foetidissima  exhibited antidiarrhoeal activity in animal models.  
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9. CONCLUSION 
  
 From the present research work, it is concluded that the ethanolic 
leaf extract of Kedrositis foetidissima selected for pharmacological 
screening with a special reference to anti-diarrhoeal activity. 
Traditionally the leaves of Kedrositis foetidissima was used to control 
diarrhoea. Literature review on Kedrositis foetidissima reveals the plant 
possess antimicrobial, antitumor and wound healing activity. 
Phytochemical analysis shows the presence of triterpeniods saponins, 
carbhohydrates, tannins, flavanoids , resins, sterols etc. Kedrositis 
foetidissima leaf extract exhibited anti-diarrhoeal property in dose 
dependent manner in three different models. Further study has to be 
conducted by isolating the active principal responsible for anti-diarrhoeal 
property which may add a new herb anti-diarrhoeal agent. 
 
REFERENCES 
 
Department of pharmacology Page 49 
 
10. REFERENCES 
          
Adey emi OO, Akindele AJ. Antidiarrhoeal activity of  the ethyl acetate  extract 
of  Baphia nitida (Papilionaceae). Journal  of  Ethnopharmacology  2008; 
116:407-412. 
Adeyemi OO, Aigbe FR , Badru OA. The  Antidiarrhoeal activity of the 
aqueous root extract of  Aristolochia ringens (Vahl.) Aristolochiaceae.  
Nigerian  Quarterly Journal of Hospital Medicine 2012; 22(1):29-33. 
Agbor GA, Leopold T, Jeanne NY. The antidiarrhoeal activity of  Alchornea 
cordifolia leaf extract. Phytotherapy Research 2004;18(11):873-6. 
Akter R, Hasan SMR, Jamila M, Rahman S. In Vitro Antioxidant and In Vivo 
Antidiarrhoeal Activity of Hydromethanolic Extract of Xanthium 
Indicum Koenig. Leaves. European Journal of Scientific Research 2009; 
33(2):305-312. 
Altman DF. Drugs used in gastrointestinal diseases 2001. 
Amabeoku GJ. Antidiarrhoeal activity of Geraniumincanum Burm. f. 
(Geraniaceae) leaf aqueous extract in mice. Journal of 
Ethanopharmacology 2009; 123(1):190-193. 
REFERENCES 
 
Department of pharmacology Page 50 
 
Amutha M , Lalitha P. Evaluation of Wound Healing Activity of Leaf and Stem 
Extract of Kedrostis Foetidissima (Jacq.) Cogn.  Research Journal of 
Pharmaceutical, Biological and Chemical Sciences 2013; 4(2):445 – 449. 
Balaji G, Chalamaiah M, Ramesh B, Reddy YA. Antidiarrhoeal activity of 
ethanol and aqueous extracts of  Carum copticum seeds in experimental 
rats. Asian Pacific Journal of Tropical Biomedicine 2012; 1151-1155. 
Biswas S, Murugesan T, Sinha S, Maiti K, Gayen JR, Pal M, Saha BP. 
Antidiarrhoeal activity of Strychnos potatorumseed extract in rats. 
Fitoterapia 2002; 73(1):43-7. 
Chitme HR, Chandra R, Kaushik S. Studies on anti-diarrheal activity of  
Calotropis gigantean R.BR. in experimental animals. J Pharm  
Pharmaceut Sci 2004; 7 (1):70-75. 
Choene M and Motadi LR. Anti-proliferative effects of the methanolic extract 
of kedrostis foetidissima in breast cancer cell lines. Molecular Biology 
2012; 107:1-5.  
Ezeja IM, Ezeigbo II, Madubuike KG, Udeh NE, Ukweni IA, Akomas SC, 
Ifenkwe DC. Antidiarrheal activity of Pterocarpus erinaceus methanol 
leaf extract in experimentally-induced diarrhea. Asian Pacific Journal of 
Tropical Medicine 2012; 5(2):147-50. 
REFERENCES 
 
Department of pharmacology Page 51 
 
Harborne JB, Phytochemical methods: A guide to modern techniques of plant 
analysis, 3rd edition, Chapman and Hall, London, 2007. 
Hassan KA, Brenda AT, Patrick V, Patrick OE. In vivo antidiarrheal activity of 
the ethanolic leaf extract of Catharanthus roseus Linn. (Apocyanaceae) in 
Wistar rats. African Journal of Pharmacy and Pharmacology 2011; 
5(15):1797-1800. 
Karanayil RS, Barij NS, Aiyolu R. Antidiarrheal activity of  Capparis zeylanica 
leaf extracts.  Journal of Advanced   Pharmaceutical Technology  and  
Research 2011; 2(1) 39-42. 
Karmakar UK, Rahman MA, Sadhu SK, Ali ME. Chemical and biological 
investigations of Coriandrum sativum Linn. International Journal of 
Pharmaceutical Sciences and Research 2011; 2(4):999-1006. 
Karthik P, Kumar RN, Amudha P. Anti Diarrheal Activity of the Chloroform 
Extract of Cayratia PedataLam in Albino Wistar Rats. 
Pharmacologyonline 2011; 69-75. 
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. 
Harrison's Principles of Internal  Medicine. McGraw-Hill, New York 
2005; 189-197. 
REFERENCES 
 
Department of pharmacology Page 52 
 
Katzung BG, Editor, Basic and Clinical Pharmacology, 8th ed. McGraw-Hill, 
San Francisco  1070-1071.  
King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among 
children: oral rehydration, maintenance, and nutritional therapy. MMWR 
Recomm Report 2003; 52 (RR-16): 1–16. 
Kokate CK. Practical Pharmacognosy. 4th edition, Vallabh Prakashan, New 
Delhi, India, 1994. 
Li L. Opportunity and challenge of traditional Chinese medicine in face of the 
entrance to WTO (World Trade Organization). Chin. Inform. trad. Chin. 
Med 2000; 7:7–8. 
Magaji MG, Yaro AH, Mohammed A, Zezi AU, Tanko Y, Bala TY. 
Preliminary antidiarrhoeal activity of methanolic extracts of Securinega 
virosa (Euphorbiaceae). African Journal of Biotechnology 2007; 24. 
Maniyar Y, Bhixavatimath P, Agashikar NV. Antidiarrheal activity of flowers 
of Ixora Coccinea Linn. in rats. Journal of Ayurveda and Integrative 
medicine 2010; 1(4):287-91. 
Martindale .The Complete Drug Reference. Pharmaceutical Press, London, 
Electronic Version 2005. 
REFERENCES 
 
Department of pharmacology Page 53 
 
Mohammed A, Ahmed H, Goji ADT, Okpanachi AO, Ezekiel I,Tanko Y. 
Preliminary Anti-diarrhoeal Activity of Hydromethanolic Extract of 
Aerial Part of Indigofera Pulchra.in Rodents.  Asian Journal of Medical 
Sciences 2009; 1(2):22-25. 
Morgan K. Medicine of  the Gods: Basic Principles of Ayurvedic Medicine 
2002. 
Mujumdar AM, Misar AV, Upadhye AS. Antidiarrhoeal  activity of ethanol 
extract of  the bark of  Dalbergia lanceolaria. Journal of 
Ethanopharmacology 2005; 102(2):213-6. 
Nirmala J, Pandian R, Morphological and Systematic studies on Kedrostis 
foetidissima (Jacq.) Cogn. Int.J.Curr.Microbiol.App.Sci 2013; 2(10):560-
571. 
Okokon JE, Akpan HD, Umoh EE. Antidiarrhoeal and antiulcer activities of 
Hippocratea Africana root extract. Pak. J. Pharm. Sci 2011; 24(2):201-
205. 
Panchawat S, Sisodia SS. Evaluation of Anti-Diarrhoeal Activity of Stem Bark 
Extracts of Ficus religiosa  Prepared by Different Methods of Extraction. 
International Journal of Pharmaceutical & Biological Archives 2012; 
3(1):218-222. 
REFERENCES 
 
Department of pharmacology Page 54 
 
Ragupathy S. Malasars medicinal utility of the flora in the Velliangiri hills:     
          Journal of Ethnobiology and Ethnomedicine , 2008. 
Rao HJ, Lakshmi. Antidiarrhoeal activity of the aqueous extract of the bark of 
Cinnamomum zeylanicum Linn  in  mice. Journal of Clinical and 
Diagnostic Research 2012; 6(2):215-219. 
Saito H. Regulation of herbal medicines in Japan. Pharmacol. Regul 2000; 41, 
515–519. 
Schulz V, Hansel R, Tyler VE. Rational Phytotherapy. A Physician’s Guide to 
Herbal Medicine, 4th Ed., Berlin, Springer-Verlag 2001. 
Senthil Nagaraj D and Venkateswarlu B.  Pharmacological studies of anti-
diarrhoeal activity of vernonia cinerea in experimental animals. 
International Journal of  Pharmacological Screening Methods 2013, 3(1); 
16-21. 
Seshadri SD, Ashok KBS, Dhanasekaran S, Suresh B. Anti-inflammatory and 
Antidiarrhoeal Activities of Ethanol Extract of Ipomea obscura. 
Pharmacology online 2007; 1:424-435. 
Shaikat ZH, Hossain T, Azam G. Phytochemical Screening and Antidiarrhoeal 
Activity of Hyptis suaveolens. International Journal of Applied Research  
in Natural Products 2012; 5(2):1-4. 
REFERENCES 
 
Department of pharmacology Page 55 
 
Sharma P, Vidyasagar G, Bhandari A, Singh S, Bhadoriya U, Ghule S, Dubey 
NA. Pharmacological evaluation of antidiarrhoeal activity of leaves 
extract of Murraya koenigii in experimentally induced diarrhoea in rats. 
Asian Pacific Journal of Tropical Disease 2012; 230-233. 
Shaw D. Risks or remedies ? Safety aspects of  herbal remedies. J. Roy. Soc. 
Med 1998; 91:294–296. 
Shiramane RS, Biradar KV, Chivde BV. In-vivo antidiarrhoeal activity of 
ethanolic extract of Delonix regia flowers in experimental induced 
diarrhoea in wistar albino rats. International Journal of Research in 
Pharmacy and Chemistry 2011; 1(3):442-447. 
Sini JM, Umar IA, Anigo KM. Antidiarrhoeal activity of aqueous extract of 
Combretum sericeum roots in rats. African Journal of Biotechnology 
2008; 7(17):3134-3137. 
Tabuti, JRS, Lye KA, Dhillion SS. Traditional herbal drugs of Bulamogi, 
Uganda: plants, use and administration: Journal of Ethnopharmacology  
2003; 88: 19-44. 
Waller DG, Renwick AG, Hillier K. Medical Pharmacology and Therapeutics, 
2nd ed. Elsevier  Saunders, London, 2005; 417-418. 
REFERENCES 
 
Department of pharmacology Page 56 
 
Weber DM. The diarrhoeal diseases and food borne illnesses. In:Hunter GW, 
Swartzwelder JC, Clyde DF, (Eds.), Tropical  medicine, 5th Edition WB. 
Saunders Co. , Philadelphia.1976. 
WHO Research Guidelines for Evaluating the Safety and Efficacy of Herbal 
Medicines, Manila. 1993. 
Wilson ME. Diarrhoea in non travelers: risk and etiology. Clinical Infectious 
Diseases 2005; 41(8): 541–546. 
